Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: John O'Neill who wrote (438)	5/3/1998 10:42:00 PM
From: muddphudd	Read Replies (1) \| Respond to of 2135

Most people don't know about ENMD because it only recently caught the media's attention. Prior to that only MDs, researchers, and seasoned investors who work in the field, follow biotech, or read the scientific literature knew much about the exciting potential of angiogenesis. Folkman has been working on this for the better part of 2 decades! As for tomorrow....don't make the same mistake I made when I first bought my shares of ENMD. I would not buy unless you want to play the short-term game (very short). I'd buy on the pull back after the market calms down. There is nothing to sustain the price above 12-ish. This news coverage may drive it up to 14-15 but it will come back. Unless, ofcourse, news comes out during the next couple of weeks. Which leads me to ask whether we know anything substantial about the ENMD-JNJ connection??? Anyone?